Corrigendum: Guanxin Danshen formulation protects against myocardial ischemia reperfusion injury-induced left ventricular remodeling by upregulating estrogen receptor β

[This corrects the article DOI: 10.3389/fphar.2017.00777.].

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2024-10, Vol.15, p.1488968
Main Authors: Deng, Xuehong, Xing, Xiaoyan, Sun, Guibo, Xu, Xudong, Wu, Haifeng, Li, Guang, Sun, Xiaobo
Format: Article
Language:English
Subjects:
estrogen receptor β
Guanxin Danshen formula
myocardial ischemia reperfusion injury
network pharmacology
Pharmacology
PI3K/Akt
ventricular remodeling
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[This corrects the article DOI: 10.3389/fphar.2017.00777.].
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2024.1488968